Smith & Nephew: poised to deliver share price recovery
The UK’s largest medical equipment company appears to offer an appealing risk/reward ratio for investors after a challenging 2020.
Covid-19 has had a profound effect on the performance of medical device company Smith & Nephew (LON:SN). Pandemic-related restrictions have prompted a fall in elective surgeries in key markets including the US and Europe, which has had a very negative impact on its financial performance.
Continue reading our content…
- Unlimited access to our market-beating portfolios
- In-depth coverage of many of the world’s great companies
- Unique insights from our top research team
- Company and markets insights
- Sponsored content
- Podcasts
Previous article Next article
DON'T MISS OUT!
Get top investment ideas to help safeguard and grow your wealth.
Invaluable insight from the exciting world of smaller companies.
REGISTER FREE
More on Smith & Nephew
Smith & Nephew: poised to deliver share price recovery
The UK’s largest medical equipment company appears to offer an appealing risk/reward ratio for investors after…
Brexit: ten stocks to prepare your portfolio
With one month to go, businesses are still worried about the potential of leaving the EU…
